A detailed history of Principle Wealth Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Principle Wealth Partners LLC holds 6,613 shares of LLY stock, worth $5.89 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
6,613
Previous 6,509 1.6%
Holding current value
$5.89 Million
Previous $5.06 Million 18.25%
% of portfolio
0.48%
Previous 0.42%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $75,386 - $94,540
104 Added 1.6%
6,613 $5.99 Million
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $51,521 - $68,928
87 Added 1.35%
6,509 $5.06 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $325,617 - $383,860
620 Added 10.69%
6,422 $3.74 Million
Q3 2023

Nov 01, 2023

BUY
$434.7 - $599.3 $69,986 - $96,487
161 Added 2.85%
5,802 $3.12 Million
Q2 2023

Jul 31, 2023

BUY
$350.74 - $468.98 $13,678 - $18,290
39 Added 0.7%
5,641 $2.65 Million
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $684,939 - $804,428
2,205 Added 64.91%
5,602 $1.92 Million
Q4 2022

Feb 02, 2023

BUY
$321.55 - $374.67 $48,232 - $56,200
150 Added 4.62%
3,397 $1.24 Million
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $449 - $558
2 Added 0.06%
3,247 $897,000
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $216,660 - $280,248
-1,200 Reduced 27.0%
3,245 $745,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $328,759 - $435,027
2,520 Added 130.91%
4,445 $750,000
Q4 2019

Feb 04, 2020

SELL
$106.92 - $132.43 $57,202 - $70,850
-535 Reduced 21.75%
1,925 $253,000
Q3 2019

Nov 05, 2019

BUY
$106.79 - $116.16 $262,703 - $285,753
2,460 New
2,460 $275,000
Q2 2019

Nov 05, 2019

SELL
$110.79 - $129.32 $192,220 - $224,370
-1,735 Closed
0 $0
Q1 2019

Oct 30, 2019

SELL
$111.31 - $131.02 $25,044 - $29,479
-225 Reduced 11.48%
1,735 $225,000
Q4 2018

Oct 11, 2019

BUY
$105.9 - $118.64 $207,564 - $232,534
1,960 New
1,960 $227,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $847B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Principle Wealth Partners LLC Portfolio

Follow Principle Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principle Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principle Wealth Partners LLC with notifications on news.